Sodium Bicarbonate → HCID 23155775, compound
Reaction equation
C(OC([N:11]1[CH2:23][C:22]2[S:21][C:20]3[N:19]=[C:18]([CH2:24][CH2:25][CH2:26][CH2:27][N:28]4[CH2:33][CH2:32][N:31]([C:34]5[CH:43]=[CH:42][C:41]6[C:36](=[CH:37][CH:38]=[CH:39][CH:40]=6)[N:35]=5)[CH2:30][CH2:29]4)[NH:17][O:16][C:15]=3[C:14]=2[CH2:13][CH2:12]1)=O)C1C=CC=CC=1.Br.C(O)(=O)C.C(=O)([O-])O.[Na+]>>[N:35]1[C:36]2[C:41](=[CH:40][CH:39]=[CH:38][CH:37]=2)[CH:42]=[CH:43][C:34]=1[N:31]1[CH2:32][CH2:33][N:28]([CH2:27][CH2:26][CH2:25][CH2:24][C:18]2[NH:17][O:16][C:15]3[C:14]4[CH2:13][CH2:12][NH:11][CH2:23][C:22]=4[S:21][C:20]=3[N:19]=2)[CH2:29][CH2:30]1Participants
4
Procedure
To 100 mg of 7-benzyloxycarbonyl-2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-3,4,5,6,7,8-hexahydro-4-oxa-9-thia-1,3,7-triaza-9H-fluorene as synthesized in Example 3-14, 5 ml of hydrogen bromide-acetic acid solution was added and stirred at room temperature. After neutralizing the system with saturated aqueous sodium hydrogencarbonate solution, the reaction product was extracted with chloroform, dried over anhydrous magnesium sulfate and concentrated to provide 78 mg (100%) of 2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-3,4,5,6,7,8-hexahydro-4-oxa-9-thia-1,3,7-triaza-9H-fluorene.
Workup
- additionwas added
- extractionthe reaction product was extracted with chloroform
- dry with materialdried over anhydrous magnesium sulfate
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-92291c85d91d4fa28e6857e2f88ead38
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07799775B2
Reaction notes
Loading…